Hosted on MSN

BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid “Pivot to Growth” Strategy Execution

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks under $100. On October 9, BofA raised the firm’s price target on Teva to $24 from $22, while keeping a Buy rating ...
Forbes

Eight Steps To Pivoting With Purpose And For Profit

To pivot or not to pivot—that is the question. In today's hyper-competitive environment, business agility can be very important for capitalizing on new opportunities, adapting to rapid changes and ...